About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00039013

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

This is a multicenter, randomized, blinded, placebo-controlled study to assess the effects on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes. Patients will be random...

Lead sponsor: AstraZeneca•129 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

AstraZeneca

Age

16 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subjects with Type 2 diabetes mellitus
•Treated with metformin within a defined dose range for at least 3 months prior to screening
•BMI= 27-45 kg/m2
•HbA1c value between 7.5% and 11%

Exclusion Criteria

•Treated with oral anti-diabetic medications other than metformin within 3 months of screening
•Patients treated previously with AC2993
•Patients presently treated with insulin

Related studies

Milk for Diabetes Prevention

NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more

RECRUITINGPhase 4

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

NCT07112339 · Diabetes Mellitus, Type 2

Food Insecurity Reduction & Strategy Team

NCT06329375 · Diabetes Mellitus, Type 2, Food Insecurity, and more

RECRUITINGPhase 1

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

NCT06945406 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

NCT06959901 · Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment336

Start dateMar 2002

Last updatedFeb 24, 2015

Condition

Diabetes Mellitus, Type 2

Locations shown

Pinnacle Research Group

Anniston, Alabama

Parkway Medical Center

Birmingham, Alabama

Alabama Clinical Therapeutics

Birmingham, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2015Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions